
Keeping you informed with the latest company updates and investment insights from renowned stock market professionals:
Company Q&A – Hear directly from company management as they discuss the latest updates and strategic developments.
Small-Cap Investing – UK equity analyst and market commentator Paul Scott joins Paul Hill to discuss their latest views on a range of stocks.

New Harena Resources chairman joins Vox to update on the recent fundraise and progress at Ampasindava

Watch on YouTube or listen on audioboom
Harena Resources has undertaken a fundraising to bring in new strategic investors and to provide working capital as it continues to progress its Ampasindava rare earths project in Madagascar. The project is close to attaining a mining licence and a bankable feasibility study is likely to follow shortly thereafter. Harena's new chairman Ivan Murphy takes us through the likely sequence of events, and gives a broad outline of the company's strategy and the opportunities in rare earths that it's addressing.
Q&A with KEFI's Executive Chairman, Harry Anagnostaras-Adams

Watch on YouTube on listen on Audioboom
KEFI Gold and Copper has released a comprehensive update on the ongoing progress it's making with the Tulu Kapi gold project in Ethiopia. Sign-offs have begun in regard to the financing package for the project, and final close is expected next month. Meanwhile, early work on site has been going well ahead of full launch. KEFI's chairman Harry Anagnostaras-Adams joins Vox with further detail, and reminds us once again of the huge potential profits that are on offer here. He also voices his aspiration, down the line, to pay a dividend to shareholders
Interview with CEO, Sara Barrington of Verici DX

Watch on YouTube on listen on Audioboom
In this upbeat interview, CEO Sara Barrington of Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through:
00:00 Verici's £6.35m recent fund raise and planned use of proceeds.
02:45 Commercialisation of its flagship blood test Tutivia.
09:20 $300m total addressable market for Tutivia
21:35 Relationship with Thermo Fisher Scientific (re pre-graft Clarava/PTRA test)
24:15 Update on 3rd diagnostic (Protega) and closing remarks

Small-cap Investing with Paul Hill and Paul Scott

Watch on Youtube or listen on Audioboom
In this week’s smallcap investing show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 23 stock


